Member Info for tqhussain

Didn't expect to see it at these levels.

I really hope one of the tests mentioned in the link below is the AZ serology test that Proaxsis is validating.

https://www.gov.uk/government/publications/serology-testing-strategy-for-discussion-at-sage-4-june-2020/serology-testing-strategy-for-discussion-at-sage-4-june-2020

https://jobs.bcm.edu//job/Houston-Research-Coordinator-II-Texa/824806200/?source=CareerArc

Saw this fairly new job ad which would suggest further trials for Glycotest?

NSCI acquire net assets of £0.8m for £192k

Nice update, things are going to plan.
Q1 22 will be very interesting.

The technical issues with the trials must be well under control if the company expects the following;
'Expected introduction targeted for early 2022'

Another good indicator that things have gone well will be the $4m tranche Fosun, fingers crossed.

GLA

https://twitter.com/gonggasgirl/status/1460544007788847118?s=21

Anyone got a link to the presentation? wasn't aware one was taking place.

I just added another £5k.

This is way to low now.

SW lol, yes meant to say MAST.

MUST is another one of my holdings and nothing to do with KIBO.

In the report under assets there is no mention of MUST so I guess the holding in MUST is hidden under cash & cash equivalents.

Actual cash in hand position is not very clear to me.

Sad news indeed, I saw him posting on a number of boards over the years.

RIP Sir

In the half year report it shows Kibo have £4.8m cash but I can't see where this came from? beside the warrants exercised did Kibo do a fundraise (I can't see a RNS)?

What's not clear to me is that Fosun acquired a 40% stake for $10m funding back in 2018 (BTW $3-4m of that funding is still outstanding) so how is our our controlling interest at 64%?

Based on what the non-controlling party paid, yes, it values Glycotest at $30m.
Nicely highlighted Jimzi/Zombi!

Makes me wonder if he had stop losses triggered.

Sagetech have been busy presenting/promoting this month. I saw a tweet this week from a medical person mentioning Sagetech in positive light. I am expecting an update next week.

Highlights

· Issue of 561,505,950 Subscription Shares at 1.0p per Subscription Share to Grosvenor for 29.9 per cent. of the enlarged issued share capital of the Company;

· Grosvenor is a new South African private company formed by young black entrepreneurs who wish to expand their investments and mining operations in South Africa beyond the bulk commodities space and develop high-value vertically integrated projects;

· The Subscription Price of 1.0 pence per Subscription Share represents a premium of 62.3 per cent. compared to the 20-day VWAP of 0.616 pence and a premium of 90.5 per cent. to the mid market price of 0.525 pence on 29 March 2021, being the last trading day prior to the announcement that Ironveld was in discussions that might lead to a material transaction;

· Ironveld and Grosvenor have agreed that Grosvenor will nominate two non-executive Directors to Ironveld's Board following completion of the Subscription; and

· The Subscription is conditional on shareholder approval being granted at a general meeting of the Company (the "General Meeting"). The Company will publish a circular together with a notice to convene the General Meeting in the coming days.

Funding at 1p.

Great news

'While the trial is experiencing a slight administrative delay, we are pleased to report that the PDS0101 trial recruitment has progressed well and it is anticipated that it will resume recruitment shortly.'

Big overreaction to PDSB news, its a delay nothing more.
PDSB holding up pretty well.